Extract
Advaxis Management Discusses FY2009 on Results Call.
Highlights, Milestones and Future Growth Strategy
NORTH BRUNSWICK, N.J. -- Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, conducted its fiscal year end re...See the full content of this document
Sponsored links
